RPAY vs SURG
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPAY is a Hold and SURG is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RPAY’s FA Score shows that 0 FA rating(s) are green whileSURG’s FA Score has 2 green FA rating(s).
- RPAY’s FA Score: 0 green, 5 red.
- SURG’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RPAY’s TA Score shows that 3 TA indicator(s) are bullish while SURG’s TA Score has 3 bullish TA indicator(s).
- RPAY’s TA Score: 3 bullish, 4 bearish.
- SURG’s TA Score: 3 bullish, 4 bearish.
Price Growth
RPAY (@Packaged Software) experienced а -0.83% price change this week, while SURG (@Packaged Software) price change was -21.31% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was +1.25%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was -2.89%.
Reported Earning Dates
RPAY is expected to report earnings on Nov 06, 2024.
SURG is expected to report earnings on Nov 12, 2024.
Industries' Descriptions
@Packaged Software (+1.25% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
| RPAY | SURG | RPAY / SURG | |
| Capitalization | 979M | 75.9M | 1,290% |
| EBITDA | 78.3M | 20.1M | 390% |
| Gain YTD | -2.342 | -77.674 | 3% |
| P/E Ratio | 54.35 | 2.85 | 1,906% |
| Revenue | 297M | 137M | 217% |
| Total Cash | 118M | 14.6M | 808% |
| Total Debt | 443M | 5.44M | 8,137% |
RPAY | SURG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 58 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 79 Overvalued | 65 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 12 | |
PRICE GROWTH RATING 1..100 | 63 | 95 | |
P/E GROWTH RATING 1..100 | 78 | 1 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SURG's Valuation (65) in the null industry is in the same range as RPAY (79). This means that SURG’s stock grew similarly to RPAY’s over the last 12 months.
SURG's Profit vs Risk Rating (100) in the null industry is in the same range as RPAY (100). This means that SURG’s stock grew similarly to RPAY’s over the last 12 months.
SURG's SMR Rating (12) in the null industry is significantly better than the same rating for RPAY (94). This means that SURG’s stock grew significantly faster than RPAY’s over the last 12 months.
RPAY's Price Growth Rating (63) in the null industry is in the same range as SURG (95). This means that RPAY’s stock grew similarly to SURG’s over the last 12 months.
SURG's P/E Growth Rating (1) in the null industry is significantly better than the same rating for RPAY (78). This means that SURG’s stock grew significantly faster than RPAY’s over the last 12 months.
| RPAY | SURG | |
|---|---|---|
| RSI ODDS (%) | about 1 month ago 0% | about 1 month ago 0% |
| Stochastic ODDS (%) | about 1 month ago 0% | about 1 month ago 0% |
| Momentum ODDS (%) | about 1 month ago 0% | about 1 month ago 0% |
| MACD ODDS (%) | about 1 month ago 0% | about 1 month ago 0% |
| TrendWeek ODDS (%) | about 1 month ago 0% | about 1 month ago 0% |
| TrendMonth ODDS (%) | about 1 month ago 0% | about 1 month ago 0% |
| Advances ODDS (%) | N/A | N/A |
| Declines ODDS (%) | about 2 months ago 81% | about 2 months ago 0% |
| BollingerBands ODDS (%) | about 1 month ago 0% | about 1 month ago 0% |
| Aroon ODDS (%) | about 1 month ago 0% | about 1 month ago 0% |
RPAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, RPAY has been loosely correlated with ALRM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RPAY jumps, then ALRM could also see price increases.
| Ticker / NAME | Correlation To RPAY | 1D Price Change % | ||
|---|---|---|---|---|
| RPAY | 100% | -1.42% | ||
| ALRM - RPAY | 46% Loosely correlated | -2.27% | ||
| QTWO - RPAY | 45% Loosely correlated | -2.64% | ||
| BIGC - RPAY | 44% Loosely correlated | -1.19% | ||
| IIIV - RPAY | 44% Loosely correlated | -2.96% | ||
| SSNC - RPAY | 43% Loosely correlated | -1.38% | ||
More | ||||
SURG and
Correlation & Price change
A.I.dvisor tells us that SURG and RSKD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SURG and RSKD's prices will move in lockstep.
| Ticker / NAME | Correlation To SURG | 1D Price Change % | ||
|---|---|---|---|---|
| SURG | 100% | -12.20% | ||
| RSKD - SURG | 30% Poorly correlated | -3.67% | ||
| RXT - SURG | 29% Poorly correlated | -3.91% | ||
| RPAY - SURG | 26% Poorly correlated | -1.42% | ||
| REKR - SURG | 25% Poorly correlated | -5.60% | ||
| MYPS - SURG | 24% Poorly correlated | -2.63% | ||
More | ||||